RT-AR001

N/A

Report date: 2023/05/22 10:20:09
NME

Base Information

Drug NameRT-AR001
Drug Alias NameRT-AR001
ClassificationSmall molecules
Mechanisms of ActionAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInspyr Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesInspyr Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A